IRELAND | WP4 | |||
Organization | UCD | |||
Name of cohort | All-Ireland Infectious Diseases Cohort | |||
Referring partner | UCD (Ireland) | |||
Cohort Information | Country(-ies), cities, regions or centers involved | St Vincent's University Hospital Dublin, Mater Misericordiae University Hospital Dublin, Beaumont University Hospital Dublin, Our Lady's Children's Hospital Dublin, Our Lady of Lourdes Hospital Drogheda, Sligo University Hospital, University Hospital Limerick, Cork University Hospital, , University Hospital Galway, Teagasc Food Research Centre, Wexford General Hospital. | ||
Time of data collection | 01/2013 | Ongoing | ||
Enrolment | Active | |||
Study setting | Multi-centers | |||
Population | Age | Adults | ||
Type | Both | |||
Total number of patients | 70 | |||
Type of frailty (WP4) | ||||
Data collection | Clinical data | True | ||
Serological data | True | |||
Genetic data | False | |||
Sample collection | True | |||
Sample collected | Whole blood | Yes | ||
PBMC | No | |||
Dry-spot blood | No | |||
Plasma | No | |||
Serum | No | |||
Stool | No | |||
NP swabs | Yes | |||
Other | Urine | |||
Description | The All Ireland Infectious Diseases (AIID) Cohort study was initially established at a single hospital site (Mater Misericordiae University Hospital) in 2013. It has since expanded to five hospital sites across Ireland. The aim of the cohort is to create a data-rich prospective dataset derived from patients who present with suspected Infectious Diseases focusing on HIV and Hepatitis and now includes SARS-CoV-2. Patients willing to participate after an informed consent process have their routine clinical data collected, and extra blood samples taken for bio banking. |